Roberto Pili

  • 10487 Citations
  • 50 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1990 2019

Filter
Comment/debate
2010

Is this a true renaissance for the treatment of prostate cancer?

Pili, R., Dec 2010, In : Oncology (Williston Park, N.Y.). 24, 14, p. 1327-1328 2 p.

Research output: Contribution to journalComment/debate

Androgen Antagonists
Tissue Extracts
Antineoplastic Agents
Prostatic Neoplasms
Renaissance

Is this a true renaissance for the treatment of prostate cancer?

Pili, R., Dec 2010, In : Oncology. 24, 14

Research output: Contribution to journalComment/debate

Prostatic Neoplasms
Renaissance
2003

Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

Ruggeri, B., Singh, J., Gingrich, D., Angeles, T., Albom, M., Yang, S., Chang, H., Robinson, C., Hunter, K., Dobrzanski, P., Jones-Bolin, S., Pritchard, S., Aimone, L., Klein-Szanto, A., Herbert, J. M., Bono, F., Schaeffer, P., Casellas, P., Bourie, B., Pili, R. & 6 others, Isaacs, J., Ator, M., Hudkins, R., Vaught, J., Mallamo, J. & Dionne, C., Nov 1 2003, In : Cancer Research. 63, 21, p. 7543 1 p.

Research output: Contribution to journalComment/debate

Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Research
Neoplasms
N,N-dimethylglycine 3-(5,6,7,13-tetrahydro-9-((1-methylethoxy)methyl)-5-oxo-12H-indeno(2,1-a)pyrrolo(3,4-c)carbazol-12-yl)propyl ester